CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Dendreon Corporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Dendreon Corporation
1301 2nd Avenue
Phone: (206) 219-7815p:206 219-7815 Seattle, WA  98101-3906  United States Fax: (302) 655-5049f:302 655-5049

This company's Plan of Liquidation went into effect on 6/10/2015
On 9/6/2022, the Company's Chapter 11 case #14-12515 was reopened in the U.S. Bankruptcy Court for the District of Delaware for the limited purpose of considering plan administrators motion for entry of an order estimating D&O Claims at $0 for allowance and distribution purposes.
This company is no longer actively traded on any major stock exchange.

Business Summary
Dendreon Corporation, is a biotechnology company. The Company is focused on discovery, development and commercialization of therapeutics for cancer treatment. The Company’s product portfolio includes cellular immunotherapies and small molecule product candidate that could be applicable to treating multiple types of cancers.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-YesYesYes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201412/31/2013YesYesYes-Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board Douglas G.Watson 70 6/3/2014 2/1/2000
President, General Counsel, Secretary Robert L.Crotty 41 2/26/2015 2/1/2014
Chief Financial Officer, Treasurer Gregory R.Cox 49 2/26/2015 8/1/2013
9 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Corvas International, Inc 3030 Science Park Road San Diego CA United States

Business Names
Business Name
Dendreon Distribution, LLC
Dendreon Germany GmbH
Dendreon Holdings (Netherlands) B.V.
6 additional Business Names available in full report.

General Information
Outstanding Shares: 158,716,893 (As of 11/4/2014)
Shareholders: 266
Stock Exchange: OTC
Federal Tax Id: 223203193
Fax Number: (302) 655-5049
Email Address: pr@dendreon.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023